MHIG ETF — Milliman Healthcare Inflation Guard ETF

Milliman Healthcare Inflation Guard ETF (MHIG)

Updated October 16, 2026.

MHIG is an ETF. its expense ratio is 0.55%. Total return is 0.3% over the past 0.5 years, 8.7 points behind SPY at 9.0%.

Milliman Healthcare Inflation Guard ETF is an equity fund that invests in U.S. healthcare companies and healthcare supply chain companies across all market capitalizations, using a factor-based approach to determine portfolio weights. The fund does not currently distribute dividends, and it carries an expense ratio of 0.55%. It may appeal to investors seeking equity exposure to the healthcare sector with a focus on inflation dynamics, rather than those seeking current income.

MHIG performance versus SPY

Price and return data through 2026-10-16.

Total return is 0.3% over the past 0.5 years, 8.7 points behind SPY at 9.0%.

MHIG key facts

Issuer

Milliman

Asset type

ETF

Asset class

Equity

Inception date

04/20/2026

Expense ratio

0.55%

Distribution frequency

None

Last close

$20.21 (as of 2026-10-16)

AUM

$1,001,884

Average volume

7.0

How Dividend Vision calculates yield and returns

Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: Milliman; prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

MHIG risks and drawbacks

Total return has trailed SPY over the available window.

Who may consider MHIG — and who may not

It is a weaker fit for investors who need monthly cash flow (MHIG does not currently distribute); investors whose main goal is matching SPY total return. This is educational context, not a recommendation to buy or sell.

More on MHIG

• All tickers starting with M

Tagged: Healthcare.

Frequently asked questions

More securities from Milliman.